InnoCare Optoelectronics, in its joint investor conference with Innolux, announced that 2025 net profit reached NT$160 million, with an EPS of $3.84, a three-year high.

• Portfolio Optimization: InnoCare successfully pivoted toward high-margin products, including IGZO technology and smart medical imaging sensors. This shift helped the company maintain strong profitability despite raw material cost fluctuations.
• Global Footprint: To mitigate geopolitical risks and tariff barriers, InnoCare has implemented a "Glocalization" strategy. This includes localized manufacturing in India to meet digital health demands and the establishment of service centers in the Americas for real-time technical support.
• Strategic EMS Diversification: Looking into 2026, InnoCare plans to integrate EO/IR imaging technology and offer Medical EMS (Electronic Manufacturing Services) to provide a one-stop-shop for global medical device clients.

Resource: 睿生光電去年 EPS 3.84元創三年新高 深化全球在地化布局